
Flotation/IPO
Exits: May 24, 2022
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
Microba makes tracks to ASX
The gut microbiome drug developer went public in a $22.5m offering priced at the foot of its range.
Exits: February 7, 2022
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
SenseTime scores $851m in initial public offering
The producer of image recognition technology stemmed from Chinese University of Hong Kong’s Media Lab has gone public in Hong Kong as the Chinese government introduces new regulations governing foreign IPOs.
Exits: November 26, 2021
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
Entrada Therapeutics enters Nasdaq
The Ohio State spinout has gone public in an upsized IPO sized at approximately $182m.
Pyxis progresses to stock market
Having priced its shares at the top of its range, UChicago spinout Pyxis Oncology suffered a drop on the first day of trading.
Exscientia expands IPO to over $350m
The cancer drug developer has closed its initial public offering after underwriters exercised the greenshoe option.
Other News
Pyxis picks price range
UChicago spinout Pyxis Oncology is aiming to raise more than $153m in its initial public offering, having set a price range of $14 to $16.
Exscientia establishes Nasdaq listing
The Dundee spinout has raised more than $304m in its IPO in the US, with another $160m secured through a concurrent private placement.
Li-S Energy celebrates market debut
Based on research at Deakin University, Li-S Energy has gone public on the Australian Stock Exchange after raising $25m in its initial public offering.
Lucid Diagnostics lines up IPO
Case Western Reserve University-linked Lucid Diagnostics is seeking an initial public offering that would net it up to $57.5m.
Oxford Nanopore sets IPO plans in motion
Oracle has signed up to be a cornerstone investor for Oxford Nanopore’s initial public offering, putting up half of the $410m target.
Editor's Picks
McBride moves along to M12
M12, a Microsoft Venture Fund, has hired Jason McBride as a partner, after working as the corporation's director of business development for two years
Porsche's IPO follows CVC activity
In the run-up to the float, Porche's investment arm had invested in 18 companies, from hypercars to EV batteries and even bikes.
The Standout Six: The deals you need to know about this week
Healthcare companies may be driving a public markets recovery while Lunar Energy, helmed by Tesla's former head of energy, has emerged from stealth with $300m.
Deezer agrees $1.1bn reverse merger
The audio streaming service is set to list with help from a PIPE deal featuring Orange, Access Industries, Warner Music, UMG and Media Participations.